title: Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma.
abstract: The mammalian target of rapamycin (mTOR) has emerged as a critical effector in cell growth, proliferation, survival, angiogenesis, and autophagy through direct interaction with mTORC1 (mTOR complex 1) and mTORC2 (mTOR complex 2). The mTOR axis is aberrantly activated in about 50% of human hepatocellular carcinoma (HCC) cases and thus has become an attractive target for drug development in this disease. Allosteric inhibitors of mTORC1, rapamycin and its derivatives have been used to study in patients with HCC but have not shown significant clinical utility, likely because of the lack of inhibition of mTORC2. In the present study, we describe that AZD2014, a small molecular ATP-competitive inhibitor of mTOR, was a highly potent inhibitor of mTORC1 and mTORC2 in human HCC cells, which led to a more thorough inhibition of mTORC1 than rapamycin, and the inhibition of mTORC2 prevented the feedback activation of AKT signaling. Compared with rapamycin, AZD2014 resulted in more profound proliferation suppression, apoptosis, cell cycle arrest, and autophagy in HCC cells. Notably, we found blockage of both mTORC1 and mTORC2 by AZD2014 to be more efficacious than blockage of mTORC1 alone by rapamycin in inhibiting the migration, invasion and EMT progression of HCC cells. In conclusion, our current results highlight mechanistic differentiation between rapamycin and AZD2014 in targeting cancer cell proliferation, cell cycle, apoptosis, autophagy, migration, invasion and EMT progression, and provide support for further investigation of AZD2014 as an antitumor agent for the treatment of HCC in clinic.
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Hui
authors: H
authors: Liao
authors: Department of Laboratory Medicine, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Yu
authors: Y
authors: Huang
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Botang
authors: B
authors: Guo
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Bo
authors: B
authors: Liang
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Xincheng
authors: X
authors: Liu
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Huohui
authors: H
authors: Ou
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Chenglong
authors: C
authors: Jiang
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Xianghong
authors: X
authors: Li
authors: Department of Hepatobiliary Surgery, Nanfang Hospital Affiated to Southern Medical University Guangzhou, Guangdong, PR China.
authors: Dinghua
authors: D
authors: Yang
keywords: AZD2014; EMT; Hepatocellular carcinoma; autophagy; mTOR kinase inhibitor
references: J Cell Biol. 2007 Jul 30;178(3):437-51
references: 17646396
references: Nat Rev Drug Discov. 2006 Aug;5(8):671-88
references: 16883305
references: Autophagy. 2014 Jan;10(1):70-9
references: 24262949
references: Leukemia. 2012 Jun;26(6):1195-202
references: 22143671
references: Lancet. 2012 Mar 31;379(9822):1245-55
references: 22353262
references: J Biol Chem. 2009 Mar 20;284(12):8023-32
references: 19150980
references: J Hepatol. 2012 Jan;56(1):176-83
references: 21835141
references: Cell Res. 2009 Jan;19(1):89-102
references: 19050696
references: Curr Oncol Rep. 2012 Apr;14(2):129-38
references: 22350330
references: Gastroenterology. 2008 Dec;135(6):1972-83, 1983.e1-11
references: 18929564
references: Int J Cancer. 2012 Feb 1;130(3):491-6
references: 21898386
references: J Clin Invest. 2011 Apr;121(4):1231-41
references: 21490404
references: Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17414-9
references: 18955708
references: Methods Mol Biol. 2014;1170:113-44
references: 24906312
references: Science. 2005 Feb 18;307(5712):1098-101
references: 15718470
references: Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80
references: 22037041
references: Cancer Res. 2010 Jan 15;70(2):621-31
references: 20068177
references: Bioorg Med Chem Lett. 2013 Mar 1;23(5):1212-6
references: 23375793
references: Biochim Biophys Acta. 2010 Apr;1803(4):435-42
references: 20116405
references: Cell. 2010 Apr 2;141(1):52-67
references: 20371345
references: Curr Pharm Des. 2012;18(19):2766-77
references: 22475451
references: Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
references: 24556840
references: Cancer Res. 2011 May 1;71(9):3246-56
references: 21430067
references: Oncotarget. 2014 May 30;5(10):3012-22
references: 24931142
references: Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35
references: 21157483
references: Cancer Res. 2010 Nov 15;70(22):9360-70
references: 20978191
references: J Am Coll Cardiol. 2009 Dec 15;54(25):2435-46
references: 20082935
references: Biochim Biophys Acta. 2010 Mar;1804(3):433-9
references: 20005306
references: Cell Res. 2007 Aug;17(8):666-81
references: 17680028
references: Cell Cycle. 2010 Sep 1;9(17):3470-8
references: 20703092
references: Cell Res. 2007 Oct;17 (10 ):839-49
references: 17893711
references: Cell. 2006 Oct 6;127(1):125-37
references: 16962653
references: Dev Cell. 2006 Dec;11(6):859-71
references: 17141160
references: PLoS Med. 2008 Jan 22;5(1):e8
references: 18215105
references: Cancer Cell. 2007 Jul;12(1):9-22
references: 17613433
references: Aging Cell. 2012 Aug;11(4):668-74
references: 22577861
references: Nat Rev Mol Cell Biol. 2013 Mar;14(3):133-9
references: 23361334
references: Cancer Cell. 2010 Mar 16;17(3):249-61
references: 20227039
references: Dig Liver Dis. 2012 Jul;44(7):610-6
references: 22459565
references: Cancer. 2011 Nov 15;117(22):5094-102
references: 21538343
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: Cancer Lett. 2013 Oct 28;340(1):1-8
references: 23792225
references: N Engl J Med. 2011 Sep 22;365(12):1118-27
references: 21992124
references: Oncogene. 2006 Nov 9;25(53):7029-40
references: 16715128
references: PLoS Biol. 2009 Feb 10;7(2):e38
references: 19209957
references: J Cell Sci. 2012 Mar 1;125(Pt 5):1259-73
references: 22399812